These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14047820)

  • 1. L-METHIONINE AND L-TRYPTOPHAN FEEDINGS IN NON-PSYCHOTIC AND SCHIZOPHRENIC PATIENTS WITH AND WITHOUT TRANYLCYPROMINE.
    ALEXANDER F; CURTIS GC; SPRINCE H; CROSLEY AP
    J Nerv Ment Dis; 1963 Aug; 137():135-42. PubMed ID: 14047820
    [No Abstract]   [Full Text] [Related]  

  • 2. URINARY INDOLES IN SCHIZOPHRENIC AND PSYCHONEUROTIC PATIENTS AFTER ADMINISTRATION OF TRANYLCYPROMINE (PARNATE) AND METHIONINE OR TRYPTOPHAN.
    SPRINCE H; PARKER CM; JAMESON D; ALEXANDER F
    J Nerv Ment Dis; 1963 Sep; 137():246-51. PubMed ID: 14051939
    [No Abstract]   [Full Text] [Related]  

  • 3. HYPERTENSION WITH METHIONINE IN SCHIZOPHRENIC PATIENTS RECEIVING TRANYLCYPROMINE.
    BULL C; VALVERDE JM; BERLET HH; SPAIDE JK; TOURLENTES TT; HIMWICH HE
    Am J Psychiatry; 1964 Oct; 121():381-2. PubMed ID: 14211416
    [No Abstract]   [Full Text] [Related]  

  • 4. TREATMENT OF ATYPICAL DEPRESSION DEPRESSION WITH LIBRIUM AND PARNATE.
    KEARNEY TR
    Dis Nerv Syst; 1964 Jul; 25():443-7. PubMed ID: 14178700
    [No Abstract]   [Full Text] [Related]  

  • 5. TREATMENT OF ATYPICAL DEPRESSION WITH LIBRIUM AND PARNATE.
    KEARNEY TR
    Dis Nerv Syst; 1964 Jul; 25():443-7. PubMed ID: 14180140
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
    Berlet HH; Matsumoto K; Pscheidt GR; Spaide J; Bull C; Himwich HE
    Arch Gen Psychiatry; 1965 Dec; 13(6):521-31. PubMed ID: 5841751
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDIES ABOUT A NEW DRUG ASSOCIATION].
    OBARRIO JM; FERRERO RG; FABREGAS G
    Sem Med; 1963 Jul; 123():71-3. PubMed ID: 14091087
    [No Abstract]   [Full Text] [Related]  

  • 8. DEATH ASSOCIATED WITH TRANYLCYPROMINE AND CHEESE.
    CUTHILL JM; GRIFFITHS AB; POWELL DE
    Lancet; 1964 May; 1(7342):1076-7. PubMed ID: 14132611
    [No Abstract]   [Full Text] [Related]  

  • 9. THE EFFECT OF ARGININE GLUTAMATE ON ELEVATED BLOOD AMMONIA LEVELS IN CHRONIC LIVER DISEASE.
    DAVEY MG
    Australas Ann Med; 1964 Feb; 13():72-6. PubMed ID: 14122205
    [No Abstract]   [Full Text] [Related]  

  • 10. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
    Spaide J; Neveln L; Tolentino J; Himwich HE
    Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
    [No Abstract]   [Full Text] [Related]  

  • 11. METABOLIC STUDIES WITH THE DIURETIC TRIAMTERENE IN PATIENTS WITH CIRRHOSIS AND ASCITES.
    GINSBERG DJ; SAAD A; GABUZDA GJ
    N Engl J Med; 1964 Dec; 271():1229-35. PubMed ID: 14234267
    [No Abstract]   [Full Text] [Related]  

  • 12. THE EFFECTS OF WITHDRAWAL OF TRIFLUOPERAZINE ON PATIENTS MAINTAINED ON THE COMBINATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY.
    JANECEK J; SCHIELE BC; BELLVILLE T; ANDERSON R
    Curr Ther Res Clin Exp; 1963 Dec; 5():608-15. PubMed ID: 14084030
    [No Abstract]   [Full Text] [Related]  

  • 13. [SUCCINET REFLECTIONS ON THE CLINICAL USE OF ANTIDEPRESSIVE AGENTS].
    BOBON J; GOFFIOUL F; COLLARD J; BREULET M
    Encephale; 1964; 53():479-84. PubMed ID: 14222722
    [No Abstract]   [Full Text] [Related]  

  • 14. TREATMENT OF HYPERTENSION IN NEUROPSYCHIATRIC PRACTICE--THE CLINICAL APPLICATION OF L-TRYPTOPHAN.
    STEIN SI
    J Neuropsychiatr; 1963 Jun; 4():296-309. PubMed ID: 14047827
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECTS OF REDUCTION OF TRYPTOPHAN AND METHIONINE INTAKE ON URINARY INDOLE COMPOUNDS AND SCHIZOPHRENIC BEHAVIOR.
    BERLET HH; SPAIDE J; KOHL H; BULL C; HIMWICH HE
    J Nerv Ment Dis; 1965 Apr; 140():297-304. PubMed ID: 14330437
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Life Sci I; 1970 Sep; 9(18):1021-32. PubMed ID: 5478406
    [No Abstract]   [Full Text] [Related]  

  • 17. A COMPARISON OF TRANYLCYPROMINE ALONE WITH TRANYLCYPROMINE PLUS TRIFLUOPERAZINE IN THE TREATMENT OF CHRONIC OUTPATIENTS: A DOUBLE-BLIND CONTROLLED STUDY.
    MENA A; HEISTAD G; SCHIELE BC; JANECEK J
    J Neuropsychiatr; 1964 Dec; 5():542-50. PubMed ID: 14246556
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of amino acid feedings in schizophrenic patients treated with iproniazid.
    POLLIN W; CARDON PV; KETY SS
    Science; 1961 Jan; 133(3446):104-5. PubMed ID: 13736870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PATIENTS' RESPONSE TO TRANYLCYPROMINE WITHDRAWAL.
    GARETZ FK; CASPERSON P
    Am J Psychiatry; 1964 Jul; 121():72. PubMed ID: 14154787
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.